Great Lakes Advisors LLC Makes New $4.48 Million Investment in Henry Schein, Inc. $HSIC

Key Points

• Great Lakes Advisors LLC acquired 65,363 shares of Henry Schein, Inc. for approximately $4.48 million, representing a 0.05% stake in the company as reported in a recent SEC filing.
• Henry Schein's stock had a price-to-earnings ratio of 21.82 and a market capitalization of $8.20 billion, with a recent trading range between $60.56 and $82.49 over the past year.
• Analysts have mixed ratings for Henry Schein with a consensus price target of $76.67, where five analysts recommend a Buy and seven a Hold rating.

Great Lakes Advisors LLC bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 65,363 shares of the company's stock, valued at approximately $4,477,000. Great Lakes Advisors LLC owned 0.05% of Henry Schein as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Clearline Capital LP bought a new stake in Henry Schein in the 1st quarter worth about $16,095,000. Jones Financial Companies Lllp grew its position in Henry Schein by 24,351.3% in the 1st quarter. Jones Financial Companies Lllp now owns 542,330 shares of the company's stock worth $37,144,000 after purchasing an additional 540,112 shares in the last quarter. Teza Capital Management LLC bought a new position in shares of Henry Schein during the 1st quarter valued at approximately $260,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Henry Schein by 1.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,859 shares of the company's stock valued at $1,155,000 after acquiring an additional 229 shares during the period. Finally, Hawk Ridge Capital Management LP bought a new position in shares of Henry Schein during the 1st quarter valued at approximately $19,684,000. 96.62% of the stock is owned by institutional investors.

Henry Schein Stock Down 0.8%

NASDAQ HSIC traded down $0.54 during trading hours on Friday, reaching $69.01. 1,115,039 shares of the company's stock traded hands, compared to its average volume of 1,429,852. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The firm has a market cap of $8.37 billion, a PE ratio of 22.26, a PEG ratio of 2.29 and a beta of 0.86. The firm has a 50-day simple moving average of $69.32 and a 200 day simple moving average of $69.48. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business had revenue of $3.24 billion for the quarter, compared to analysts' expectations of $3.22 billion. During the same period last year, the business earned $1.23 earnings per share. The company's revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently commented on HSIC shares. UBS Group cut their price objective on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a report on Wednesday, August 6th. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Sunday, September 7th. Evercore ISI upgraded shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price objective on the stock in a research report on Tuesday, August 26th. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Finally, Barrington Research reduced their target price on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a report on Wednesday, August 6th. Five research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $76.67.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.